As of 2025-12-15, the Relative Valuation of Moderna Inc (MRNA) is (112.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 29.46 USD, the upside of Moderna Inc based on Relative Valuation is -481.7%.
The range of the Relative Valuation is (114.37) - (114.85) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 14.4x | 12.3x |
| Forward P/E multiples | 14.3x - 16.7x | 15.9x |
| Fair Price | (114.37) - (114.85) | (112.46) |
| Upside | -488.2% - -489.9% | -481.7% |
| Date | P/E |
| 2025-12-12 | -3.69 |
| 2025-12-11 | -3.71 |
| 2025-12-10 | -3.64 |
| 2025-12-09 | -3.54 |
| 2025-12-08 | -3.51 |
| 2025-12-05 | -3.47 |
| 2025-12-04 | -3.20 |
| 2025-12-03 | -3.16 |
| 2025-12-02 | -3.02 |
| 2025-12-01 | -3.03 |
| 2025-11-28 | -3.26 |
| 2025-11-26 | -3.14 |
| 2025-11-25 | -3.10 |
| 2025-11-24 | -3.03 |
| 2025-11-21 | -2.97 |
| 2025-11-20 | -2.80 |
| 2025-11-19 | -3.03 |
| 2025-11-18 | -3.12 |
| 2025-11-17 | -3.10 |
| 2025-11-14 | -3.11 |
| 2025-11-13 | -3.13 |
| 2025-11-12 | -3.35 |
| 2025-11-11 | -3.31 |
| 2025-11-10 | -3.10 |
| 2025-11-07 | -3.08 |
| 2025-11-06 | -3.05 |
| 2025-11-05 | -2.95 |
| 2025-11-04 | -2.98 |
| 2025-11-03 | -3.12 |
| 2025-10-31 | -3.41 |
| 2025-10-30 | -3.53 |
| 2025-10-29 | -3.10 |
| 2025-10-28 | -3.18 |
| 2025-10-27 | -3.34 |
| 2025-10-24 | -3.35 |
| 2025-10-23 | -3.29 |
| 2025-10-22 | -3.37 |
| 2025-10-21 | -3.45 |
| 2025-10-20 | -3.42 |
| 2025-10-17 | -3.26 |
| 2025-10-16 | -3.40 |
| 2025-10-15 | -3.48 |
| 2025-10-14 | -3.29 |
| 2025-10-13 | -3.35 |
| 2025-10-10 | -3.36 |
| 2025-10-09 | -3.45 |
| 2025-10-08 | -3.50 |
| 2025-10-07 | -3.43 |
| 2025-10-06 | -3.45 |
| 2025-10-03 | -3.57 |